rs141812371
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_022095.4(ZNF335):c.3507C>T(p.His1169His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00073 in 1,613,904 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 5 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 2 hom. )
Consequence
ZNF335
NM_022095.4 synonymous
NM_022095.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0480
Publications
3 publications found
Genes affected
ZNF335 (HGNC:15807): (zinc finger protein 335) The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. [provided by RefSeq, Jul 2008]
ZNF335 Gene-Disease associations (from GenCC):
- microcephalic primordial dwarfism due to ZNF335 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 20-45950050-G-A is Benign according to our data. Variant chr20-45950050-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.048 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00384 (585/152330) while in subpopulation AFR AF = 0.0127 (526/41566). AF 95% confidence interval is 0.0118. There are 5 homozygotes in GnomAd4. There are 288 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZNF335 | NM_022095.4 | c.3507C>T | p.His1169His | synonymous_variant | Exon 23 of 28 | ENST00000322927.3 | NP_071378.1 | |
| ZNF335 | XM_047440363.1 | c.3507C>T | p.His1169His | synonymous_variant | Exon 22 of 27 | XP_047296319.1 | ||
| ZNF335 | XM_005260504.5 | c.3504C>T | p.His1168His | synonymous_variant | Exon 22 of 27 | XP_005260561.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF335 | ENST00000322927.3 | c.3507C>T | p.His1169His | synonymous_variant | Exon 23 of 28 | 1 | NM_022095.4 | ENSP00000325326.2 |
Frequencies
GnomAD3 genomes AF: 0.00384 AC: 584AN: 152212Hom.: 5 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
584
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00104 AC: 260AN: 249738 AF XY: 0.000881 show subpopulations
GnomAD2 exomes
AF:
AC:
260
AN:
249738
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000406 AC: 593AN: 1461574Hom.: 2 Cov.: 33 AF XY: 0.000363 AC XY: 264AN XY: 727086 show subpopulations
GnomAD4 exome
AF:
AC:
593
AN:
1461574
Hom.:
Cov.:
33
AF XY:
AC XY:
264
AN XY:
727086
show subpopulations
African (AFR)
AF:
AC:
446
AN:
33474
American (AMR)
AF:
AC:
49
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39690
South Asian (SAS)
AF:
AC:
3
AN:
86206
European-Finnish (FIN)
AF:
AC:
0
AN:
53312
Middle Eastern (MID)
AF:
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
32
AN:
1111938
Other (OTH)
AF:
AC:
53
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00384 AC: 585AN: 152330Hom.: 5 Cov.: 33 AF XY: 0.00387 AC XY: 288AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
585
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
288
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
526
AN:
41566
American (AMR)
AF:
AC:
49
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68028
Other (OTH)
AF:
AC:
3
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
27
54
81
108
135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Dec 04, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
Sep 17, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Microcephalic primordial dwarfism due to ZNF335 deficiency Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.